INTERNATIONAL PATENT: GALIMEDIX THERAPEUTICS INC. FILES APPLICATION FOR "USE OF LECANEMAB IN OPHTHALMOLOGICAL CONDITIONS"

GENEVA, Aug. 11 -- GALIMEDIX THERAPEUTICS INC. (3704 Calvend LaneKensington, Maryland 20895) filed a patent application (PCT/IB2025/051134) for "USE OF LECANEMAB IN OPHTHALMOLOGICAL CONDITIONS" on Feb 03, 2025. With publication no. WO/2025/163607, the details related to the patent application was published on Aug 07, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): RUSS, Hermann Kurt (Grandeur Residences - Mughal C-Go5The Palm Jumeirah PO# 922477Dubai)

Abstract: This disclosure related to a method of preventing or treating an amyloid- associated retinal disease in an individual in need the...